Effects of droperidol on the pancreatic and biliary sphincters

Gastrointestinal Endoscopy

Volumn 58, Issue 4, 2003, Pages 488-492

  Fogel, Evan L ^a   Sherman, Stuart ^a   Bucksot, Lois ^a   Shelly, LeeAnn ^a   Lehman, Glen A ^a  

^a INDIANA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; BENZODIAZEPINE DERIVATIVE; CYCLOBENZAPRINE; DIAZEPAM; DIPHENHYDRAMINE; DROPERIDOL; MECLOZINE; MIDAZOLAM; NARCOTIC ANALGESIC AGENT; PETHIDINE; PROMETHAZINE;

ADULT; AGED; AGITATION; ARTICLE; CARDIOTOXICITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG SAFETY; DRUG TOLERABILITY; DRUG UTILIZATION; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; EVALUATION; FEMALE; HUMAN; LONG QT SYNDROME; LOW DRUG DOSE; MALE; MANOMETRY; ODDI SPHINCTER; PARAMETER; PRESSURE MEASUREMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITATIVE ANALYSIS; SEDATION; SIDE EFFECT; TORSADE DES POINTES; WAVEFORM;

EID: 0141706608     PISSN: 00165107     EISSN: None     Source Type: Journal    
DOI: 10.1067/S0016-5107(03)01541-4     Document Type: Article

References (41)

1. Lehman GA. Endoscopic sphincter of Oddi manometry: a clinical practice and research tool. Gastrointest Endosc 1991;37: 490-1.
2. Lans JL, Parikh NP, Geenen JE. Application of sphincter of Oddi manometry in routine clinical investigations. Endoscopy 1991;23:139-43.
3. Sherman S, Lehman GA. Opioids and the sphincter of Oddi. Gastrointest Endosc 1994;40:105-6.
4. Sherman S, Gottlieb K, Uzer MF, Smith MT, Khusro QE, Earle DT, et al. Effects of meperidine on the pancreatic and biliary sphincter. Gastrointest Endosc 1996;44:239-42.
5. Elta GH, Barnett JL. Meperidine need not be proscribed during sphincter of Oddi manometry. Gastrointest Endosc 1994; 40:7-9.
6. Reed WD, Hopkins BE, Joske RA, Laurence BH. A comparative study of conventional premedication (pethidine, promethazine, and atropine) and neuroleptanalgesia (droperidol and phenoperidine) for peroral endoscopy. Gut 1971;12:736-8.
7. LeBrun HI. Neuroleptanalgesia in upper alimentary endoscopy. Gut 1976;17:655-8.
8. Rubin J, Bryer JV, Brock-Utne JG, Moshal MG. The use of neurolept analgesia for gastro-intestinal endoscopy. S Afr Med J 1977;52:835-7.
9. Rozen P, Ratan J, Gilat T. Fentanyl-droperidol neuroleptanalgesia in gastrointestinal endoscopy. Gastrointest Endosc 1977;23:142-4.
10. Moshal MG, Rubin J, Greenberg MJ, Spitaels JM, Bryer JVO, White E. Variable premedication for upper gastrointestinal endoscopy. Am J Gastroenterol 1979;71:158-63.
11. Wilcox CM, Forsmark CE, Cello JP. Utility of droperidol for conscious sedation in gastrointestinal endoscopic procedures. Gastrointest Endosc 1990;36:112-5.
12. Claussen D. Droperidol (Inapsine). Gastroenterol Nurs 1993; 16:81-2.
13. Barthel JS, Marshall JB, King PD, Afridi A, Gibb LG, Madsen R. The effect of droperidol on objective markers of patient cooperation and vital signs during esophagogastroduodenoscopy: a randomized, double-blind, placebo-controlled, prospective investigation. Gastrointest Endosc 1995;42:45-50.
14. Cohen J, Haber GB, Dorais JA, Scheider DM, Kandel GP, Kortan PP, Marcon NE. A randomized, double-blind study of the use of droperidol for conscious sedation during therapeutic endoscopy in difficult to sedate patients. Gastrointest Endosc 2000;51:54651.
15. Wille RT, Barnett JL, Chey WD, Scheiman JM, Elta GH. Routine droperidol pre-medication improves sedation for ERCP. Gastrointest Endosc 2000;52:362-6.
16. Rizzo J, Bernstein D, Gress F. A randomized double-blind placebo-controlled trial evaluating the cost-effectiveness of droperidol as a sedative premedication for EUS. Gastrointest Endosc 1999;50:178-82.
17. Sherman S, Troiano FP, Hawes RH, Lehman GA. Sphincter of Oddi manometry: decreased risk of clinical pancreatitis with use of a modified aspirating catheter. Gastrointest Endosc 1990;36:462-6.
18. Nebel OT. Manometric evaluation of the papilla of Vater. Gastrointest Endosc 1975;21:126-8.
19. Staritz M, Meyer Zum Buschenfelde KH. Investigation of the effect of diazepam and other drugs on the sphincter of Oddi motility. Ital J Gastroenterol 1986;18:41-3.
20. Cuer JC, Dapoigny M, Bommelaer G. The effect of midazolam on motility of the sphincter of Oddi in human subjects. Endoscopy 1993;25:384-6.
21. Rolny P, Arleback A. Effect of midazolam on sphincter of Oddi motility. Endoscopy 1993;25:381-3.
22. Ponce Garcia J, Garrigues V, Sala T, Pertejo V, Berenguer J. Diazepam does not modify the motility of the sphincter of Oddi [letter]. Endoscopy 1988;20:87.
23. Fazel A, Burton FR. A controlled study of the effect of midazolam on abnormal sphincter of Oddi motility. Gastrointest Endosc 2002;55:637-40.
24. Economou G, Ward-McQuaid JN. A cross-over comparison of the effect of morphine, pethidine, pentazocine, and phenazocine on biliary pressure. Gut 1971;12:218-21.
25. Greenstein AJ, Kaynan A, Singer A, Dreiling DA. A comparative study of pentazocine and meperidine on the biliary passage pressure. Am J Gastroenterol 1972;58:417-27.
26. Radnay PA, Brodman E, Mankikar D, Duncalf D. The effect of equianalgesic doses of fentanyl, morphine, meperidine and pentazocine on common bile duct pressure. Anaesthesist 1980;29:26-9.
27. Dedrick DF, Tanner WW, Bushkin FL. Common bile duct pressure during enflurane anesthesia. Arch Surg 1980;115: 820-2.
28. McCammon RL, Stoelting R, Madura JA. Reversal of fentanyl induced spasm of the sphincter of Oddi. Surg Gynecol Obstet 1983;156:329-34.
29. McCammon RL, Stoelting R, Madura JA. Effects of butorphanol, nalbuphine and fentanyl on intrabiliary tract dynamics. Anesth Analg 1984;63:139-42.
30. Joehl RJ, Koch KL, Nahrwold DL. Opioid drugs cause bile duct obstruction during hepatobiliary scans. Am J Surg 1984; 147:134-8.
31. Helm JF, Venu RP, Geenen JE, Hogan WJ, Dodds WJ, Toouli J, Arndorfer RC. Effects of morphine on the human sphincter of Oddi. Gut 1988;29:1402-7.
32. Wiedmeyer DA. Stewart ET, Taylor AJ. Radiologic evaluation of structure and function of the sphincter of Oddi. Gastrointest Endosc Clin N Am 1993;3:13-40.
33. Kroesen G, Bodner E, Russe W, Troyer E, Geir W. The influences of anesthetic methods on intraoperative cholangiometry. Anaesthesist 1978;1:21-4.
34. Wilcox CM, Linder J, Price J, Irwin S, Coffey E, Arguedas M. Prospective evaluation of droperidol on sphincter of Oddi manometry [abstract]. Gastrointest Endosc 2001;53:82.
35. Corazziari E, Torsoli A. Sphincter of Oddi manometry: recording techniques, trace interpretation, and reproducibility. Gastrointest Endosc Clin N Am 1993;3:81-92.
36. Thune A, Scicchitano J, Roberts-Thompson I, Toouli J. Reproducibility of endoscopic sphincter of Oddi manometry. Dig Dis Sci 1991;36:1401-5.
37. Sloan R, Cohen H. Midazolam with or without meperidine does not influence basal sphincter of Oddi pressures (BSOP) [abstract]. Am J Gastroenterol 1993;88:1529.
38. Guy JM, Andre-Fouet X, Porte J, Bertrand M, Lamaud M, Verneyre H. Torsade de pointe and prolongation of the duration of the QT-interval after injection of droperidol. Ann Cardiol Angeiol 1991;40:541-5.
39. Lischke V, Behne M, Doelken P, Schledt U, Probst S, Vettermann J. Droperidol causes a dose-dependent prolongation of the QT interval. Anesth Analg 1994;79:983-6.
40. FDA. FDA strengthens warnings for droperidol. Rockville (MD): US Food and Drug Administration; 2001 Dec 6. Available from www.fda.gov/bbs/topics/ANSWERS/2001/ANS01123.html.
41. Horowitz BZ, Bizovi K, Moreno R. Droperidol: behind the black box warning. Acad Emerg Med 2002;9:615-8.